InsidersTradesSigma
Follow the 메쥬 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 메쥬 has logged 6 reports. Market capitalisation: €131bn. The latest transaction was filed on 10 April 2026 (Purchase). Among the most active insiders: 박정환. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
메쥬是一家在XKRX上市的医疗保健和制药公司。它专注于药品的开发和商业化。